Cubist Systematic Strategies’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,100
Closed -$356K 2798
2024
Q4
$356K Sell
5,100
-900
-15% -$74.7K ﹤0.01% 2328
2024
Q3
$629K Buy
6,000
+2,100
+54% +$246K ﹤0.01% 2103
2024
Q2
$555K Buy
3,900
+1,600
+70% +$184K ﹤0.01% 2078
2024
Q1
$256K Sell
2,300
-19,500
-89% -$2.32M ﹤0.01% 2954
2023
Q4
$2.83M Buy
21,800
+5,000
+30% +$689K 0.02% 1240
2023
Q3
$2.74M Sell
16,800
-15,000
-47% -$2.64M 0.02% 1142
2023
Q2
$5.83M Sell
31,800
-5,000
-14% -$720K 0.04% 736
2023
Q1
$4.9M Buy
+36,800
New +$4.32M 0.03% 950

Other funds holding ACLS

Cubist Systematic Strategies's ACLS Position: Q2 2024 in Review

Cubist Systematic Strategies sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 64,445 shares — an estimated $7.43M sold.

Cubist Systematic Strategies first reported a position in ACLS in Q1 2015 and held it in 24 quarters. The position peaked at $24.7M in Q4 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

  • Cubist Systematic Strategies reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
  • Cubist Systematic Strategies sold 64,445 Axcelis shares in Q2 2024, an estimated $7.43M.
  • Cubist Systematic Strategies first reported a position in Axcelis in Q1 2015 and held it in 24 quarters.
  • Cubist Systematic Strategies's Axcelis position peaked at $24.7M in Q4 2023.
  • 392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Cubist Systematic Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.